EMA Authorised: Oczyesa (octreotide hydrochloride) — Camurus AB

View source ↗

Summary

The EMA authorised Oczyesa (octreotide hydrochloride) from Camurus AB for the treatment of acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Oczyesa (octreotide hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Acromegaly. MAH: Camurus AB. Decision date: 02/12/2025